iktos Alternatives & Competitors
12 companies similar to iktos — Artificial intelligence for new drug design
Companies similar to iktos
Terray Therapeutics
Everything small molecule drug discovery should be.
Pasadena, United States
Variational AI
State-of-the-art generative AI for small molecule drug discovery
Canada
Bresso, Italy
Synfini, Inc.
The Agile Drug Discovery Company
Menlo Park, United States
Rival Readout
Competing with iktos? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
X-37
Utilizing advanced AI to discover new drug candidates by scanning extensive libraries of c...
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
San Mateo, United States
Paris, France
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Boston, United States
Cellarity
Rewriting the rules of drug creation
Somerville, United States
Diffuse Bio
We build generative AI for protein therapeutics.
A-Alpha Bio
The protein-protein interaction company
Seattle, United States
AnaBios Corporation
The Power of the Human Model
San Diego, United States
About iktos
Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's proprietary generativ...
Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics
Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams
Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization
B2B, SaaS, Platform
Subscription, Project Based, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around iktos: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at iktos on 20 Sep 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
